Rapid CoViD-19 test kits
for all common strains 

Our Products

CoViD-19 Detection Kit

Clinical significance: According to the “New Coronavirus Pneumonia Infection Diagnosis and Treatment Plan” (Trial Version 5) the CoViD 19 nucleic acid test is the gold standard for the diagnosis of suspected patients.

Product Characteristics

Accurate results: the kit contains an internal standard to avoid false negative results and ensure the accuracy of the test result.

Anti-pollution: the principle of “One step” PCR technology reduces reaction time and avoids aerosol pollution.

High sensitivity: the minimum detection baseline is 500 copies/mL, which ensures the detection of low virus content sample results.

High-throughput: triple PCR reaction system, high detection flux, timely and rapid completion of multiple sample detection.

CE-IVD and CFDA approved.

Covid-19-variants.jpg
CoViD-19 Nucleic Acid Detection Kit (VARIANTS)
1 tube – 4 tests – 45 minutes PCR time

COVID-19 common strain, UK, South African and P2 Brazilian variants

Clinical significance: According to the “New Coronavirus Pneumonia Infection Diagnosis and Treatment Plan” (Trial Version 5) the CoViD 19 nucleic acid test is the gold standard for the diagnosis of suspected patients.

The kit is able to identify simultaneously and in 1 tube only the presence of the COVID-19 common strain, the UK, the South African and the P2 Brazilian variants.

The kit is compatible with the most common RT-PCR instrument.

Product Characteristics

Accurate results: the kit contains an internal standard to avoid false negative results and ensure the accuracy of the test result.

Anti-pollution: the principle of “One step” PCR technology reduces reaction time and avoids aerosol pollution.

High sensitivity: the minimum detection baseline is 500 copies/mL, which ensures the detection of low virus content sample results.

High-throughput: triple PCR reaction system, high detection flux, timely and rapid completion of multiple sample detection.

CE-IVD approved

Sars-Cov-2 Antigen Fast Test Kit
Intended Use

For qualitative detection of the nucleocapsid protein antigen of SARS-CoV-2 in nasopharyngeal and nasal swab, and saliva specimensfrom individuals and is aid in rapid diagnosis of patientswith suspected SARS-CoV-2 infection

Features
  • Carefully selected special monoclonal antibody to the nucleocapsid protein antigen from SARS-CoV-2.

  • Various applicable specimen: Nasopharyngeal swab, Nasal swab and Saliva.

  • Easy to use, easy results interpretation by naked eyes. 

  • Test result available within 15minutes.

Test rapido per l'antigene Covid-19
Auto Test Rapido Salivare

L'uso previsto per l'antigene COVID-19 (fluido orale) e' un SELF test mono-uso destinato ad individuare il nuovo coronavirus SARS-CoV-2 che causa il COVID-19 nel fluido orale umano, il SELF test e'progettato per l'uso domestico con l'auto-raccolta dei campioni di fluido orale da individui sintomatici che si sospetta siano stati infettati dal virus COVID-19 E AUTORIZZATO DAL MINISTERO DELLA SANITA' ITALIANO.

Il SELF test rapiDo per l'antigene COVID-19 (Fluido orale) fornisce solamente un risultato preliminare, la conferma finale deve essere basata sui risultati di diagnostica clinica.

Self test Sars-Cov-2 Antigen Saliva fast test Kit
Intended Use

The COVID-19 Antigen Rapid Test (Oral Fluid) is a single-use test kit intended to detect the novel coronavirus SARS-CoV-2 that causes COVID-19 in human oral fluid. This test is designed for home use1 with self-collected oral fluid samples from symptomatic individuals who are suspected of being infected with COVID-19.  
The COVID-19 Antigen Rapid Test (Oral Fluid) obtain a preliminary results only, the final confirmation should be based on clinical diagnostic results. 

World Health Organization (WHO) has defined our types of test within the best methods for the detection and identification of SARS-CoV-2 and variants.

OaCP and its kit have been listed as certified entities in the Circular of Italy’s Ministry of Health published on 04/03/2020. The document contains updates about indications on diagnostic tests and criteria to follow in the determination of priorities within COVID-19 pandemic.